Neurological Outcomes of Primary Intracerebral Haemorrhage Admitted in Intensive Care Unit at the University Hospital of Grenoble Alpes

Neurological Outcomes of Primary Intracerebral Haemorrhage

Sponsors

Lead sponsor: University Hospital, Grenoble

Source University Hospital, Grenoble
Brief Summary

The main objective of this study is to determine the one-year neurological outcome of patients admitted to an intensive care unit (ICU) for a primary and spontaneous supratentorial intracerebral hemorrhages (ICH).

Detailed Description

ICH represent a diagnostic and therapeutic emergency. ICH account for 20% of strokes with a one-year mortality of more than 45% and an uncertain neurological outcome.

For ICH patients, the main initial challenge is to determine the long term neurological outcomes and adapt the therapeutic strategy.

The majority of primary and spontaneous ICH studies involve patients in stroke units.

The study is an observational type 3 research with all the patients admitted in all the University Hospital of Grenoble Alpes ICUs between July 2012 and July 2017 for a primary and spontaneous supratentorial ICH

Overall Status Recruiting
Start Date April 30, 2019
Completion Date January 2020
Primary Completion Date November 2019
Study Type Observational
Primary Outcome
Measure Time Frame
Neurological outcomes One year after the stroke
Enrollment 40
Condition
Eligibility

Sampling method: Non-Probability Sample

Criteria:

Inclusion Criteria:

- Admission in one of the four University Hospital of Grenoble Alpes ICUs between July 2012 and July 2017 for primary and spontaneous supratentorial ICH.

- Not opposed to participate in a research protocol (asked by phone call)

Exclusion Criteria:

- Pediatric patient

- Infra-tentorials ICH

- No spontaneous ICH (after head trauma)

- Secondary ICH (anevrisum, arteriovenous malformation, tumor, hemorrhagic transformation, vascularitis)

- Persons referred to in Articles L1121-5 to L1121-8 of the french public health code

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Overall Contact

Last name: Catherine Portal

Phone: +33.4.76.76.67.29

Email: [email protected]

Location
facility status contact investigator Grenoble University Hospital Pierluigi Banco, MD +33.4.76.76.67.29 [email protected] Pierluigi Banco, MD Principal Investigator Samuel Bersinger, MD Sub-Investigator
Location Countries

France

Verification Date

June 2019

Responsible Party

Responsible party type: Sponsor

Has Expanded Access No
Condition Browse
Acronym HIP-REA
Patient Data Undecided
Study Design Info

Observational model: Cohort

Time perspective: Cross-Sectional

Source: ClinicalTrials.gov